Werewolf Therapeutics
HOWL
71 hedge funds and large institutions have $79.2M invested in Werewolf Therapeutics in 2024 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 12 closing their positions.
4,267% more call options, than puts
Call options by funds: $131K | Put options by funds: $3K
83% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 12
71% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 14
16% more funds holding
Funds holding: 61 → 71 (+10)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.75% less ownership
Funds ownership: 75.46% → 74.71% (-0.75%)
62% less capital invested
Capital invested by funds: $209M → $79.2M (-$130M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$6.83M |
| 2 |
Millennium Management
New York
|
+$2.62M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.85M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.69M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$7.3M |
| 2 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$5.77M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.8M |
| 4 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.62M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$1.38M |
HOWL Hedge Fund Activity: Q2 2024 in Review
71 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Werewolf Therapeutics (HOWL) for Q2 2024, worth a combined $79.2M — down 62% from $209M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new HOWL positions and 12 closed out — a net gain of 10 holders — while 24 added to existing stakes and 14 trimmed.
The largest buyer was BlackRock, adding an estimated $6.83M. The largest seller was Janus Henderson Group, cutting an estimated $7.3M.
- 71 institutional investors held Werewolf Therapeutics (HOWL) as of Q2 2024, up from 61 in Q1 2024.
- Funds reported $79.2M of Werewolf Therapeutics stock for Q2 2024, down 62% quarter-over-quarter.
- 22 funds opened new Werewolf Therapeutics positions in Q2 2024 and 12 closed out, a net change of +10 holders.
- The largest Werewolf Therapeutics buyer in Q2 2024 was BlackRock, an estimated $6.83M added.
- The largest Werewolf Therapeutics seller in Q2 2024 was Janus Henderson Group, an estimated $7.3M sold.
Based on aggregated 13F filings for Q2 2024.